#United States #Rosenberg #OCuSOFT #NORWOOD Device #Dry Eye Care

OCuSOFT Inc. Partners with NORWOOD Device & Diagnostics

OCuSOFT Inc., a leading name in eye and skin care pharmaceuticals, has recently announced a strategic co-marketing and sales partnership with NORWOOD Device & Diagnostics, a trusted provider of innovative diagnostic equipment. This agreement promises to enhance the landscape of dry eye care and ocular surface disease management.

A New Dawn for Dry Eye Treatment

With the increasing prevalence of Dry Eye and Ocular Surface Disease, the partnership aims to bridge the gap between diagnostic and therapeutic solutions. The Pro Model of NORWOOD's Nighthawk™ slit lamp system introduces cutting-edge dry eye diagnostic features such as tear meniscus height measurement, non-invasive tear breakup time assessment, and lipid layer analysis. This technology allows practitioners to thoroughly evaluate various dry eye conditions, while OCuSOFT's extensive range of therapeutic products provides a comprehensive treatment framework.

Rick Norwood, President and founder of NORWOOD Device & Diagnostics, expressed enthusiasm about the partnership, highlighting the significance of collaboration in realizing the company's full potential. He stated, "Finding the right partner was crucial for us; OCuSOFT emerged as that partner, driven by innovation and integrity. Together, we aim to revolutionize the dry eye care journey from diagnosis to effective treatment."

A Serendipitous Meeting

The roots of this collaboration trace back to a chance encounter on a flight to a trade show in Las Vegas, where Cynthia Barratt, CEO and co-founder of OCuSOFT, met Rick. Their conversation revealed significant business synergies and shared values, setting the stage for what would become a pivotal relationship in the eye care field. Barratt noted, "Our industries overlap, but what truly drew us together was each other's humble beginnings and commitment to innovation."

About OCuSOFT Inc.

Founded and headquartered in Rosenberg, Texas, OCuSOFT Inc. has made its mark with products like the OCuSOFT® Lid Scrub® family, which is recognized as the first eyelid hygiene solution on the market. The company offers a diverse selection of eye care products, including preservative-free lubricating eye drops like Retaine® MGD™. Their research facility in Southwest Texas further underscores their commitment to advancing eye care technologies.

OCuSOFT has taken significant strides in innovation, exemplified by its licensing agreement with Primera Compounding, LLC, which has led to the development of a medicated eyelid cleanser, Biune™ Eyelid Spray. This product combines their patented technology with azithromycin, showcasing their dedication to providing innovative care options.

About NORWOOD Device & Diagnostics

Established in 2009, NORWOOD Device & Diagnostics has been instrumental in supplying independent Eye Care Professionals (ECPs) across the U.S. with top-notch diagnostic tools and medical devices. Led by Rick Norwood, who possesses nearly four decades of experience in the ophthalmic industry, the company's mission revolves around innovation and high-quality customer service. Their flagship products, the Nighthawk™ and Nighthawk™ Pro slit lamps, are integral in supporting ECPs in delivering state-of-the-art vision care.

Rick Norwood has positioned his company as an exclusive importer and distributor focused on the dry eye market, ensuring clinicians can accurately diagnose and manage ocular surface disease effectively. His commitment to maintaining top-tier service aligns well with OCuSOFT's principles, laying a strong foundation for collaborative success.

A Promising Future

The partnership between OCuSOFT and NORWOOD Device & Diagnostics marks a significant advancement in the eye care industry, particularly for patients suffering from dry eye conditions. By integrating innovative diagnostics with comprehensive treatment options, both companies aim to enhance patient care and improve outcomes. As they work together, OCuSOFT and NORWOOD are set to redefine the standards of dry eye management, promising a future filled with more thorough diagnostic capabilities and effective treatments for practitioners across the country.